Where we are

Global expertise according to International standards

Our highly experienced team of experts supports a comprehensive network of 29 countries with direct presence, strategically located throughout Europe and North America. With active trials in 40 different countries, we offer access to a population of more than 900 million people within reach of your study.

Our current geographical presence

Optimapharm has 26 offices in Europe and North America. The Company also runs operations in 11 other European countries, Canada, and Israel. With a network of strategic partnerships, Optimapharm also covers regions of APAC and Latin America. See the map below for more details:

Optimapharm geographical locations

Albania | Austria | Belgium | Bosnia and Herzegovina | Bulgaria | Canada | Croatia | Cyprus | Czechia | Denmark | Estonia | Finland | France | Georgia | Germany | Greece | Hungary | Ireland | Israel | Italy | Latvia | Lithuania | Luxembourg | Moldova | Montenegro | Netherlands | Norway | Poland | Portugal | Republic of North Macedonia | Romania | Serbia | Slovakia | Slovenia | Spain (x 2 offices) | Sweden | Switzerland | United Kingdom | United States

Leading mid-sized, full-service CRO

As a globally operating leading mid-sized, full-service CRO, we give unrivalled access to Patients and Investigators worldwide. This is an important factor in our ability to reliably expedite patient recruitment and deliver accurate results to clinical research projects in a cost-effective and timely manner.

With three hubs strategically located in Western Europe’s and Nordic’s more mature markets and our recent expansion in the US, we can accommodate any trials from a broad geographic and demographic spread. Numerous strategic scenarios for high-quality recruitment can be implemented, whether to enrol fast or supplement (save) any ongoing recruitment within or without Europe or both. Some of our countries present the benefit of accessing participants for less common therapeutic areas.

Global projects are also managed by Optimapharm with the support of a network of strategic partnerships that cover regions outside of Europe, including APAC and Latin America.